Significant changes may have occurred in France, in the population that developed malaria after travel in endemic areas, which implies that preventative strategies need to be adapted.
The Food and Drug Administration has granted an investigational treatment for severe malaria Breakthrough Therapy designation.
The vaccine, called Mosquirix, was approved by the European Medicines Agency in 2015
Frequently repeated mass administration of ivermectin during transmission season may reduce the incidence of uncomplicated malaria episodes in children living in endemic regions, according to study results published in the Lancet.1 Since 2017, when researchers at the World Health Organization suggested that the global fight against malaria had stalled,2 novel ways to prevent the transmission…
The drug artesunate will become the first-line treatment for severe malaira in the US.
An expert meeting convened at NIAID, NIH, in Rockville, Maryland, in 2016 to discuss the rationale and design of malaria vaccine trials in pregnant women.
Compared with placebo, single-dose tafenoquine significantly lowered risk for Plasmodium vivax malaria relapse at 6 months.
Chemoprophylaxis with tafenoquine is safe and effective for preventing malaria in healthy non-immune individuals challenged with blood stage P falciparum.
Placental malaria has a profound effect on the fetal immune system, and prenatal malaria exposure categories may drive heterogeneity to malaria susceptibility.
Iron deficiency may protect African children against malaria infection when defined using ferritin and transferrin saturation.
